[Preventive drug therapy of hyperbilirubinemia in full-term infants]. 1977

P Langer, and G Berg, and W Endig

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007567 Jaundice, Neonatal Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES. Icterus Gravis Neonatorum,Neonatal Jaundice,Physiological Neonatal Jaundice,Severe Jaundice in Neonate,Severe Jaundice in Newborn,Jaundice, Physiological Neonatal,Neonatal Jaundice, Physiological
D009552 Nikethamide A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229) Corethamid,Diethylnicotinamid,Nizethamid,Coramin,Coramine,Cordiamine,Nicethamide,Nicotinic Diethylamide,Diethylamide, Nicotinic
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

P Langer, and G Berg, and W Endig
February 1976, Pediatric annals,
P Langer, and G Berg, and W Endig
January 1991, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,
P Langer, and G Berg, and W Endig
January 1991, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,
P Langer, and G Berg, and W Endig
March 1985, Pediatrics,
P Langer, and G Berg, and W Endig
December 1996, Acta paediatrica (Oslo, Norway : 1992),
P Langer, and G Berg, and W Endig
June 1990, Clinics in perinatology,
P Langer, and G Berg, and W Endig
April 1971, Revista chilena de pediatria,
P Langer, and G Berg, and W Endig
January 1979, New York state journal of medicine,
P Langer, and G Berg, and W Endig
January 1975, Voprosy okhrany materinstva i detstva,
Copied contents to your clipboard!